Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib

SIMPLE SUMMARY: Previous studies reported hepatitis C virus-related hepatocellular carcinoma (HCV-HCC) patients might have better prognosis than hepatitis B virus-related HCC (HBV-HCC) patients at using sorafenib. However, the information about status of viremia was limited in these studies. We defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yuan-Hung, Huang, Tzu-Hsin, Wang, Jing-Houng, Chen, Yen-Yang, Tsai, Ming-Chao, Chen, Yen-Hao, Lu, Sheng-Nan, Hu, Tsung-Hui, Chen, Chien-Hung, Hung, Chao-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406667/
https://www.ncbi.nlm.nih.gov/pubmed/36010961
http://dx.doi.org/10.3390/cancers14163971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406667/
https://www.ncbi.nlm.nih.gov/pubmed/36010961
http://dx.doi.org/10.3390/cancers14163971

Ejemplares similares